What is the price of cervical cancer vaccine for a 29-year-old?

29-year-old women can choose the bivalent, quadrivalent or nine-valent cervical cancer vaccine. The specific choice needs to be made based on vaccination needs, vaccine supply and doctor's advice. Cervical cancer vaccine mainly prevents human papillomavirus infection, and there are differences in the virus subtypes covered by different valence types and the applicable age.

One and two-valent vaccines

The bivalent cervical cancer vaccine covers HPV types 16 and 18, which cause more than 70% of cervical cancers. The vaccine is suitable for women aged 9-45, and the vaccination schedule is one injection at 0, 1 and 6 months. For people who only need basic protection and have limited budgets, bivalent vaccines are cost-effective. After vaccination, minor reactions such as redness and swelling at the injection site and low-grade fever may occur, which usually resolve spontaneously in 2-3 days.

Second, quadrivalent vaccine

The quadrivalent cervical cancer vaccine adds protection against HPV types 6 and 11, which cause genital warts. The applicable age is 20-45 years old, and the vaccination cycle is the same as that of the second-price vaccine. It is more suitable for those who have a history of sexual contact or are concerned about genital wart protection. Observation is required for 30 minutes after vaccination to prevent allergic reactions. Breast-feeding women should consult a doctor before vaccination.

3. Nine-valent vaccine

The nine-valent cervical cancer vaccine covers 7 high-risk types and 2 low-risk types of HPV, preventing 90% of cervical cancer and 90% of genital warts. It is approved domestically for use on women aged 16-26, but in some countries the upper age limit is 45. If local policies permit and supply is sufficient, women aged 29 years old may be given priority. Pregnancy should be avoided within six months after vaccination, and those with low immune function need to be evaluated before vaccination.

4. Precautions for vaccination

All cervical cancer vaccines are most effective when administered before infection with the corresponding HPV subtype. There is no need to undergo HPV testing before vaccination, but those with cervical lesions need to be treated first. The vaccine cannot replace routine cervical cancer screening. Regular TCT and HPV examinations are still required after vaccination. Women who are allergic to yeast or who are pregnant should postpone vaccination.

5. Principle of reseeding

If you have already started vaccinating a certain type of vaccine, it is usually not recommended to switch to a higher value type midway. There is limited cross-protection data for vaccines of different valences, and the best protection can be achieved only by completing the full course of vaccination with the same valence. In case of vaccine shortage, the second/third dose can be postponed appropriately but should not exceed 12 months.

It is recommended that 29-year-old women choose the appropriate price based on their own health status, sexual history and vaccine availability, and fully communicate with their gynecologists before vaccination. Also maintain regular cervical cancer screening, avoid multiple sexual partners, and use condoms to reduce the risk of infection. Pay attention to strengthening your immunity every day and eat a balanced intake of foods rich in vitamins A, C, E and folic acid, such as broccoli, carrots and whole grains.